Sale!

Neuronal Paraneoplastic Autoantibodies Profile Test Cost

Original price was: 2,340 د.إ.Current price is: 2,110 د.إ.

-10%

The Neuronal Paraneoplastic Autoantibodies Profile Test is a specialized diagnostic tool used to detect the presence of specific autoantibodies in the blood that are associated with paraneoplastic syndromes—a group of rare disorders triggered by an immune system response to a cancerous tumor. These autoantibodies target normal components of the nervous system, leading to neurological symptoms that often precede the diagnosis of cancer. Identifying these autoantibodies can be crucial for early cancer detection and the management of neurological symptoms.

Performed at DNA Labs UAE, a leading facility in advanced diagnostic services, this test provides a comprehensive analysis of the autoantibodies related to neuronal paraneoplastic syndromes. The cost of the test is 2110 AED, reflecting the intricate processes involved in detecting these specific autoantibodies. By offering this test, DNA Labs UAE plays a pivotal role in aiding the early diagnosis and treatment planning for patients experiencing neurological symptoms that may be linked to an underlying malignancy, thereby improving patient outcomes.

Description

NEURONAL PARANEOPLASTIC AUTOANTIBODIES PROFILE Test

Test Name: NEURONAL PARANEOPLASTIC AUTOANTIBODIES PROFILE Test

Components: Amphiphysin, CV2, PNMA2(Ma2/Ta), ANNA-1/Hu, ANNA-2/Ri, PCA-1/Yo

Price: 2110.0 AED

Sample Condition: 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen.

Report Delivery: Sample Mon through Sat by 9 am; Report Same day

Method: Immunoblot

Test type: Paraneoplastic Syndromes

Doctor: Oncologist

Test Department:

Pre Test Information: No special preparation required

Test Details:

The NEURONAL (PARANEOPLASTIC) AUTOANTIBODIES PROFILE test is a diagnostic test that helps identify the presence of specific autoantibodies in the blood that are associated with paraneoplastic neurological disorders (PNDs). PNDs are a group of rare neurological disorders that are often associated with cancer.

This test is typically ordered when a patient presents with neurological symptoms that cannot be explained by other causes and there is a suspicion of an underlying cancer. The test helps to identify autoantibodies that are associated with specific PNDs, such as anti-Hu, anti-Yo, anti-Ri, anti-Ma2, and anti-CV2.

The presence of these autoantibodies can provide valuable information for the diagnosis and management of PNDs. It can help guide further investigations, such as imaging studies and tumor marker tests, to identify the underlying cancer. It can also help in determining the appropriate treatment options and monitoring the response to treatment.

The test involves taking a blood sample from the patient, which is then sent to a laboratory for analysis. The laboratory uses various techniques, such as enzyme-linked immunosorbent assay (ELISA) and immunoblotting, to detect and identify the specific autoantibodies.

It is important to note that a positive result for these autoantibodies does not confirm the presence of a PND or cancer. Further evaluation and testing, including imaging studies and biopsies, may be necessary to confirm the diagnosis.

Overall, the NEURONAL (PARANEOPLASTIC) AUTOANTIBODIES PROFILE test is a valuable tool in the diagnosis and management of paraneoplastic neurological disorders. It helps identify specific autoantibodies associated with PNDs, which can guide further investigations and treatment decisions.

Test Name	NEURONAL PARANEOPLASTIC AUTOANTIBODIES PROFILE Test
Components	AmphiphysinCV2PNMA2(Ma2/Ta) ANNA-1/HuANNA-2/ RiPCA-1/Yo
Price	2110.0 AED
Sample Condition	2 mL (1 mL min.) serum from 1 SST. Shiprefrigeratedorfrozen.
Report Delivery	Sample Mon through Satby 9 am;ReportSameday
Method	Immunoblot
Test type	Paraneoplastic Syndromes
Doctor	Oncologist
Test Department:
Pre Test Information	No special preparation required
Test Details	The NEURONAL (PARANEOPLASTIC) AUTOANTIBODIES PROFILE test is a diagnostic test that helps identify the presence of specific autoantibodies in the blood that are associated with paraneoplastic neurological disorders (PNDs). PNDs are a group of rare neurological disorders that are often associated with cancer. This test is typically ordered when a patient presents with neurological symptoms that cannot be explained by other causes and there is a suspicion of an underlying cancer. The test helps to identify autoantibodies that are associated with specific PNDs, such as anti-Hu, anti-Yo, anti-Ri, anti-Ma2, and anti-CV2. The presence of these autoantibodies can provide valuable information for the diagnosis and management of PNDs. It can help guide further investigations, such as imaging studies and tumor marker tests, to identify the underlying cancer. It can also help in determining the appropriate treatment options and monitoring the response to treatment. The test involves taking a blood sample from the patient, which is then sent to a laboratory for analysis. The laboratory uses various techniques, such as enzyme-linked immunosorbent assay (ELISA) and immunoblotting, to detect and identify the specific autoantibodies. It is important to note that a positive result for these autoantibodies does not confirm the presence of a PND or cancer. Further evaluation and testing, including imaging studies and biopsies, may be necessary to confirm the diagnosis. Overall, the NEURONAL (PARANEOPLASTIC) AUTOANTIBODIES PROFILE test is a valuable tool in the diagnosis and management of paraneoplastic neurological disorders. It helps identify specific autoantibodies associated with PNDs, which can guide further investigations and treatment decisions.